GE
Genovis
Seneste kurs
19,46 SEK
22.7.2026
Seneste
30,00 SEK
+54.16%
Opside
GENO
3 mdr.+54,16%1 kursmål
6 mdr.+54,16%3 kursmål
1 år+54,16%3 kursmål
Max 4 kursmål
Nordea
SundhedBiotechnology
Om selskabet
Genovis was founded in 1999 by Sarah Fredriksson, who was CEO of Genovis until May 2015, when she became chairman of the board. The business was initially focused on nanoparticles intended for both the preclinical and clinical market.
Genovis
